Skip to main navigation
Skip to search
Skip to main content
The Hebrew University of Jerusalem Home
Approve / Request updates on publications
Link opens in a new tab
Search content at The Hebrew University of Jerusalem
Home
Profiles
Research units
Research output
Prizes
The challenge of regulating nanomedicine: Key issues
Raj Bawa
,
Yechezkel Barenholz
, Andrew Owen
Institute for Medical Research Israel-Canada (IMRIC)
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
›
peer-review
14
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'The challenge of regulating nanomedicine: Key issues'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Nanotechnology
100%
Nanodrug
100%
Nanomedicine
100%
Nanoproducts
100%
Regulatory Agencies
50%
U.S. Food
50%
Politicians
50%
Doxil
50%
Regulatory Landscape
50%
Position Paper
50%
Knowledge Gaps
50%
Industrial Sector
50%
Balanced Approach
50%
Nanotherapeutics
50%
Ethicist
50%
Technology Transfer
50%
European Medicines Agency
50%
Regulatory Issues
50%
Legal Implications
50%
Physiologically-based Pharmacokinetic Model
50%
Policy Paper
50%
Regulatory Policy
50%
Guidance Documents
50%
Patent Office
50%
Legal Professionals
50%
Scientific Landscape
50%
Drug Companies
50%
Regulatory Guidelines
50%
Academic Sector
50%
Regulatory Submission
50%
Nano-enabled
50%
Science-based Approach
50%
Actual Needs
50%
Mechanistic Basis
50%
Pharmacology, Toxicology and Pharmaceutical Science
Nanomedicine
100%
Nano-Enabled Product
100%
Doxorubicin
50%
Physiologically Based Pharmacokinetic Modelling
50%
Biochemistry, Genetics and Molecular Biology
Pharmacokinetics
100%
Doxorubicin
100%
Social Sciences
Nanotechnology
100%